×

Five Prime Therapeutics to Present at the 2016 Jefferies Immuno-Oncology Summit

SOUTH SAN FRANCISCO, Calif., April 01, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics for cancer and inflammatory diseases, today announced that Lewis T. “Rusty” Williams, M.D., Ph.D., Founder, Chief Executive Officer and Chairman of the Board, will present at the 2016 Jefferies Immuno-Oncology Summit on Friday, April 8, 2016, at 11:00 A.M. Eastern Daylight Time.

A copy of the presentation will be available under the Investors section of the Company’s website at www.fiveprime.com. Five Prime will maintain archived slides on its website for 30 days after the conference.

About Five Prime

Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and preclinical development. For more information, please visit www.fiveprime.com.


CONTACT: Heather Rowe, Investor Relations 415-365-5737 heather.rowe@fiveprime.com

Source:Five Prime Therapeutics, Inc.